blokhin's oncology center was the first to have a team of psychologists and psychotherapists. over several years of work , specialists have understood. academic publication history of russia, which began to be published this year, there is a rush demand, the head of the publishing house science nikolai fedoseenkov said this in an exclusive interview with our channel, the multi-volume book covers the period from the birth of ancient cultures on the territory of russia to the beginning of the special operation, the full collection is planned to be released next year. before that, we lived with you according to the history of the soviet union and now. after 12 years of work, a team of more than 400 historians, we began publishing the history of russia, this is a huge job, these are 30 books, each more than a thousand pages, in the process, the publishing house science resumed publishing journals of the russian academy of sciences, said nikolai fedoseenkov, he is convinced that rumors about the death of paper books are greatly exaggerated, watch the full interview tonight in the p

blokhin's oncology center was the first to have a team of psychologists and psychotherapists. over several years of work, specialists have understood. and we can already see that this is a very good option very good results. doctors will tell colleagues about these results in detail on the forum, and apparently they are not just good, but stunning, judging by the fact that there. the center announced the recruitment of new clinical psychologists, so that there would be enough of them for ntv. in belarus, work is underway on a large-scale all patients. svetlana gordeeva, anatoly chernobrevets, pyotr shulgin and oleg gorkov, film project. a feature film is being filmed within the walls of the famous brest fortress. he was not on the lists, based on the story by boris vasiliev. and the sub-species of those who were the first to accept themselves blow of the german invaders, say the actors of the tabakerka theatre. one of the main roles is played by vladimir mashkov. in the tape, which is being prepared. in the lists was not listed one of the most difficult and emotionally heavy n

director of non -experimental diagnostics, tumor therapy, the nikolai nikolaevich blokhin national medical research center of oncologycheslav, hello, good afternoon, vyacheslav, please tell us.

blokhin center. sofia sergieva examined the fundamental differences between innovative drugs and those used before . neuroendocrine tumors are rare in clinical practice, but like any oncological disease, they require special treatment. to combat them , the blakhin oncology center introduced 177 lutetium radiopharmaceutical with a targeted effect on the tumor cell. in the affected area, it acts not as a bomber, but as a missile with a life-saving warhead, and with a clearly targeted action. the possibility of targeted radiotherapeutic treatment of these tumors has appeared, we managed to combine molecules for the isotope with an anti-field drug, which. has a targeted effect against this neuroendocrine tumor, this molecule, it finds cells neuroendocrine tumor, delivers a radioisotope there, and this radioisotope acts in the tumor and thus destroys it. the radionuclide drug is administered intravenously and spreads with the blood flow, grigory was one of the first to try it on himself, he has been fighting the tumor for 9 years. the best thing about this therapy is that you don’t have to lie down for a long time under some kind of ivs , constantly walk there with nausea, weaknes

blokhin center. sofia sergeeva found out how innovative drugs fundamentally differ from those used before. neuroendocrine tumors are rare in clinical practice, but like any oncological disease, they require special treatment. to combat them , the oncology center named after. targeted action on tumor cells. in the affected area, it acts not as a bomber, but as a missile with a life-saving warhead, and with a clearly targeted action. the possibility of targeted radiotherapy treatment of these tumors has appeared. we managed to combine a radioisotope molecule with an anti-tumor drug that has a targeted effect against this... thus destroying it. the radionuclide drug is injected intravenously and spreads with the blood flow. grigoriy was one of the first to try it on himself . he has been fighting the tumor for 9 years now. the best thing about this therapy is that you don’t have to lie under any ivs for a long time. you have to constantly walk there with nausea, weakness, and a bunch of other side effects. they gave you ivs, and after a day you were sent home. then for another three days you feel so-so, well, satisfactory, and then you can continue to live a full life.

blokhin center. sofia sergeeva found out how the innovative drug differs fundamentally from those used before . neuroendocrine tumors are rare in clinical practice, but like any oncological disease, they require. targeted action on tumor cells. in the affected area, it acts not as a bomber, but as a missile with a life-saving warhead, and with a clearly targeted action. it became possible targeted radiotherapeutic treatment of these tumors. we managed to combine molecules of the isotope with an anti-inflammatory device that has a targeted effect against this neuroendocrine tumor, and this molecule, it finds the cells of the neuroendocrine tumor, delivers the radioisotope there, and this radioisotope acts in the tumor and thus destroys it. the radionucleic drug is administered intravenously and spreads with the blood flow, grigory was one of the first to try it on himself, he has been fighting the tumor for 9 years. the most pleasant thing about this therapy is that you don't need... orosyn holboony ulsyn erchinniy site sergey evgenevich tsevelovar dasag zorna. minister of energy of the russian federation sergey evgenievich sivelev. minister of energy of mongolia, signed